US Patent 11273442 Programmable nuclease compositions and methods of use thereof
Patent 11273442 was granted and assigned to Mammoth Biosciences on March, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11273442 Programmable nuclease compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
